https://clinicaltrials.gov/ct2/show/NCT03391882?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F01%2F2019&lupd_d=14&sort=nwst
Study to Evaluate APL-130277 in Subjects With Parkinson’s Disease Complicated by Motor Fluctuations
Study
STUDY TITLE:
A Study of an Investigational Drug to See How it Affects the People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes) Compared to an Approved Drug Used to Treat People With Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes)
DESCRIPTION:
Condition: Motor OFF Episodes Associated With Parkinson’s Disease
Interventions: Drug: APL-130277; Drug: subcutaneous apomorphine
Sponsor: Sunovion
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03391882
FIRST POSTED:
Fri, 05 Jan 2018 12:00:00 EST
LAST UPDATE POSTED:
05/15/19 07:32AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03391882?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F01%2F2019&lupd_d=14&sort=nwst
